News
BLRX
0.1050
+3.45%
0.0035
BioLineRx Outlines Strategic Vision and Financial Outlook After Key Licensing Deals
TipRanks · 1d ago
BioLineRx says current cash to provide runway through 2H26
TipRanks · 1d ago
BIOLINE RX LTD: CURRENT CASH RUNWAY TO EXECUTE UPON GOALS THROUGH H2 2026
Reuters · 1d ago
Weekly Report: what happened at BLRX last week (0113-0117)?
Weekly Report · 2d ago
Nasdaq Surges Over 300 Points; State Street Earnings Top Views
Benzinga · 5d ago
S&P 500 Gains 1%; Fastenal Posts Downbeat Earnings
Benzinga · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-Bumble, Intel, Truist Financial
Reuters · 5d ago
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates
Benzinga · 5d ago
BioLineRx announces change to ratio of ADS to ordinary shares
Seeking Alpha · 5d ago
BioLineRx Adjusts ADS Ratio to Maintain Nasdaq Listing
TipRanks · 5d ago
BioLineRx Reports Change To Ratio Of American Depositary Shares To Ordinary Shares; Change In Exchange Ratio To Have Same Effect As 1-For-40 Reverse Stock Split
Benzinga · 5d ago
BioLineRx changes ratio of ADRs to ordinary shares
TipRanks · 5d ago
BIOLINE RX LTD: BOARD APPROVES CHANGE IN ADS RATIO FROM 15 TO 600 ORDINARY SHARES PER ADS, ISSUED BY BANK OF NEW YORK MELLON
Reuters · 5d ago
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Benzinga · 6d ago
Weekly Report: what happened at BLRX last week (0106-0110)?
Weekly Report · 01/13 10:16
BiolineRx Announces Major Direct Offering to Bolster Operations
TipRanks · 01/07 15:47
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 01/06 21:05
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet
Benzinga · 01/06 19:01
S&P Jumps 1%; Regional Health Properties Shares Spike Higher
Benzinga · 01/06 17:28
Biotech Alert: Searches spiking for these stocks today
TipRanks · 01/06 16:10
More
Webull provides a variety of real-time BLRX stock news. You can receive the latest news about Biolinerx through multiple platforms. This information may help you make smarter investment decisions.
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.